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Background: Successful egg cryopreservation has many potential benefits to a variety of patients. However, a
superior standard protocol describing all aspects of oocyte cryopreservation has not yet been identified. Oocyte
cryopreservation is still a technical challenge for many infertility clinics. To maintain satisfactory clinical outcomes,
there is a need to develop an easy to use, yet efficient laboratory protocol. The present study was designed to
examine if human embryos resulting from eggs frozen with an optimized vitrification protocol have similar
developmental competence as those from fresh eggs.
Methods: Twenty recipients received donated eggs vitrified with a protocol in which short exposure time to the
vitrification solution was used and 23 recipients received donated eggs and 6 patients had their own eggs vitrified
with a modified protocol in which long exposure time to the vitrification solution was used. After warming, egg
survival, fertilization, cleavage, blastocyst formation, clinical pregnancy and implantation rates were compared. The
developmental competence of eggs vitrified with the optimized protocol was further compared with fresh eggs
donated from the same donors.
Results: There was no difference in the oocyte survival, fertilization, cleavage, clinical pregnancy or implantation
rates between the short and long protocol groups. However, blastocyst formation rate was significantly (P < 0.001)
higher in the long protocol group (50.8%) than that in short protocol group (26.5%), resulting in more blastocysts
being transferred and frozen. When frozen eggs vitrified with long protocol and fresh eggs from the same donors
(12) were compared in 39 recipients, no differences were observed in terms of fertilization (86.4 vs 80.1%),
blastocyst formation (50.0 vs 59.2%), clinical pregnancy (63.2 vs 60.0%) and implantation (41.7 vs 44.7%) rates. Four
out of 6 patients had ongoing pregnancy after transfer of embryos from their own frozen eggs with a 46.2%
implantation rate.
Conclusions: These results indicate that blastocyst development is an appropriate measure for egg survival after
cryopreservation and frozen eggs have similar developmental potential as fresh eggs if they are frozen with an
optimized method.
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Successful egg cryopreservation has many potential ben-
efits for patients. For example, young women can freeze
their eggs for future use if they plan to have children
later and young cancer patients can freeze their eggs be-
fore treatment so they can have children after recovery
from cancer treatments that have ill-effects on existing
oocytes [1]. Since the first birth of an in vitro
fertilization (IVF) baby derived from fertilization of
frozen-thawed eggs in humans [2], major progress has
been made in this advanced assisted reproductive tech-
nology. There are mainly two laboratory methods to
freeze human eggs: slow freezing [2] and vitrification [3].
When slow freezing was compared with vitrification, it
was found that vitrified eggs had a better survival rate
than slow freezing [4,5]. Several reports have indicated
the inefficiency of the slow freezing technique that
results in low survival and implantation rates [6-8]. Slow
freezing can also cause spindle abnormalities [9] in
human eggs. These factors have limited wide-spread
clinical application of oocyte cryopreservation by slow
freezing [8]. Although vitrification can also cause
chromosome misalignment [10] in human oocytes, it
has better results than slow freezing if appropriate pro-
tocols are used [11,12]. Vitrification is an alternative egg
cryopreservation method that has been used recently by
many laboratories [13-17]. Because vitrification can re-
tain a high survival rate after thawing, it would appear
that vitrification will become the main egg cryopreserva-
tion technology in the future.
More than 900 egg cryopreservation babies were born
by 2009 and there was no apparent increase in congeni-
tal anomalies [18]. Recently, the American Society for
Reproductive Medicine has opined that oocyte cryo-
preservation should no longer be considered experimen-
tal [19]. A few studies have reported high clinical
pregnancy and live birth rates after transfer of the result-
ing embryos with vitrified/warmed human eggs
[13,14,20-23]. It has also been reported that embryo de-
velopment, clinical pregnancy and embryo implantation
rates are similar between fresh and cryopreserved eggs
in egg donation programs [20,24-26]. These successes
have made it possible to establish egg banks for patients
themselves and for patients with indications to receive
egg donation. However, most of the reports were based
on a Cryotop vitrification method [13,19-21,24-26] in
which complicated laboratory procedures were used
[27]. These procedures make this method difficult to be
followed by laboratory technicians.
Many factors affect survival of eggs after vitrification
[11,28-33], such as use of different cryoprotectant agents
(CPAs) [28], the concentrations of CPAs [11], exposure
time of eggs in the pre-vitrification and vitrification solu-
tions [29] and temperature used for each step [30].Different from embryo vitrification, it was found that
gradual equilibration of eggs from low concentration of
CPAs to high concentration of CPAs is one of the most
important keys for successful vitrification of human eggs
[6]. Taking into account of all these factors, various vitri-
fication protocols have been developed [20,34,35]. These
methods allow eggs to be equilibrated from low concen-
tration of CPAs to high concentration of CPAs, which is
better than direct exposure of eggs to high concentration
of CPAs [36], in which eggs may be exposed to osmotic
stress [37].
Unfortunately, a superior standard protocol describing
all aspects of oocyte cryopreservation has not yet been
identified. There are many nuances that remain between
programs. Oocyte cryopreservation is still a technical
challenge for many IVF clinics. To maintain satisfactory
clinical outcomes, there is a need to develop an easy to
use and efficient laboratory protocol. The purpose of the
present study was to evaluate the effects of exposure
time of oocytes in vitrification solution (VS) on subse-
quent oocyte survival, competence to develop to blasto-
cysts, and successful implantation after transfer. To
simplify the data analysis, this retrospective study was
limited to oocytes from anonymous donors and women
under 40 years of age who wished to limit the number
of oocytes inseminated, and cases in which sperm was
not available on the day of oocyte retrieval.
Methods
Ethics
Patients undergoing IVF, egg cryopreservation, and egg
donation signed written consents for all kinds of labora-
tory and clinical procedures. All egg donors were an-
onymous in the present study. The data was collected
from the medical records at the clinic between January
2011-August 2012, and the study was approved by the
institutional research committee at Houston Fertility In-
stitute, and the Medical Ethics Committee and Institu-
tional Review Board of the third Affiliated Hospital of
Guangzhou Medical University.
Patient preparation for egg retrieval
Volunteer oocyte donors and patients underwent con-
trolled ovarian hyperstimulation as described below.
Oocytes were inseminated if recipients were prepared
for subsequent embryo transfer. Supernumerary oocytes
were cryopreserved and stored in an egg bank. These
oocytes were subsequently thawed and inseminated if
recipients requested. In some cases of donation, all of
the oocytes were placed into the egg bank. In addition,
some patients had their oocytes cryopreserved due to
failed collection of semen on the day for egg retrieval.
Patients, donors and women cryopreserving their own
oocytes, were stimulated with a combination of Follistim
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Rockland MA, USA), Menopur (Ferring Pharmaceuti-
cals, Parsippany NJ, USA) and/or Bravella (Ferring Phar-
maceuticals) beginning 2–3 days after the onset of
menses. The initial starting total dose was 150–375 IU
and was adjusted subsequently as the stimulation pro-
gressed. To prevent an LH surge, a GnRH antagonist,
Ganirelix or Cetrorelix (Organo Inc.), was given when
the leading follicle was 13–14 mm or when the estradiol
level was 400 pg/ml. Human chorionic gonadotropin
(hCG), Ovidrel (Serono USA), or a GnRH agonist, leu-
prolide acetate (Teva North America, North Wales PA,
USA), was injected to induce final oocyte maturation
when at least two dominant follicles reached a diameter
of >18 mm. Eggs were retrieved under IV sedation via
transvaginal ultrasound between 35–37 hours after hCG
administration. Oocytes were inseminated using intracy-
toplasmic sperm injection (ICSI).
Egg vitrification
Oocytes were cultured for 3–5 hours before removing
the surrounding cumulus cells in a HEPES-buffered glo-
bal medium (IVFonline, CT, USA) containing 40 iu hya-
luronidase. Only mature (metaphase II) oocytes wereFigure 1 Schematic diagram for egg vitrification used in the study. A
of equilibration solution (ES) are made in a cover of a 60 mm culture dish
of ES using a transfer pipette for 2 minutes (2). The second ES drop is merg
Eggs are transferred from the merged solution to the third drop of ES for 5
drops of vitrification solution (VS) are made in the same culture dish (4). Eg
VS drop 3 (7). Eggs are remained in each drop for 10–20 seconds. The equ
before the time reaches 90 seconds (8). Vitrification straw is inserted to coo
90 seconds and the top end of the protective straw is sealed (9).vitrified. Vitrification was initially performed based on a
protocol in which eggs were exposed to the VS for
45 seconds (short protocol) and then was modified by
increasing the time in the VS to 90 seconds (long proto-
col). Closed vitrification straws and Irvine vitrification
kits (Irvine Scientific, Irvine CA USA) were used in this
study.
All procedures were performed at room temperature
(22-25C). Briefly, as shown in Figure 1, eggs were equi-
librated in 20 μl drop of basic solution (BS) for 1 minute
before the drop was merged to a 20 μl drop of the
equilibration solution (ES) containing 7.5% (v/v) ethyl-
ene glycol (EG) and 7.5% (v/v) dimethylsulphoxide
(DMSO) for 2 minutes, and then a second 20 μl drop of
ES was merged for another 2 minutes. The eggs were
then placed into a new 20 μl drop of ES for 5 minutes.
After equilibration, the eggs were transferred into three
20 μl drops (10~20 seconds in each drop) of VS that
was composed of 15% (v/v) EG, 15% (v/v) DMSO and
0.5 M sucrose and then loaded onto half-cutting 0.25 ml
straws. The straws were inserted into 0.5 ml protective
straws (one end was sealed) inside liquid nitrogen for
cryopreservation and then the top opening of the pro-
tective straw was sealed (Figure 1). The time from the20 μl of basic solution (BS) drop without CPAs and three 20 μl drops
(1). Eggs are placed in the BS for 1 minute and then merged to 1 drop
ed to the solution using the same transfer pipette for 2 minutes (3).
minutes (4). When the eggs are in the third drop of ES, three 20 μl
gs are transferred to VS drop 1 (5), then to VS drop 2 (6), and finally to
ilibrated eggs are finally loaded to the tip of the vitrification straw
led protective straw inside liquid nitrogen when the time reaches
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tion straw being placed in liquid nitrogen was 45 seconds
in Group A (short protocol) and 90 seconds in Group B
(long protocol). Two to three eggs were vitrified in one
straw and then the frozen eggs were stored in the liquid
nitrogen until warming for insemination.
Egg warming and insemination
Egg warming was based on the procedures previously
reported [20]. Briefly, straws were removed from liquid
nitrogen and the tips of the straws with eggs were
quickly placed in 1 ml 1.0 M sucrose that had been
warmed at 37C in an organ culture dish. After 1 minute
in the 1.0 M sucrose solution, eggs were transferred to
1 ml 0.5 M sucrose for 3 minutes and then to 1 ml BS
for 10 minutes. These procedures were performed at
room temperature (22-25C). After warming, eggs were
washed with Global medium supplemented with 10%
serum protein substitute (SPS, IVFonline CT, USA) and
then cultured in the same medium for 2–3 hours before
ICSI. Egg survival status was evaluated based on morph-
ology immediately after completion of the warming pro-
cedures and ICSI was performed by experienced
embryologists whose skill levels have been verified by
their high fertilization rates. All eggs were cultured in
Global medium supplemented with 10% SPS after ICSI.
Embryo culture and transfer
Fertilization was examined 16–18 hours after ICSI and
zygotes were cultured in Global medium supplemented
with 10% SPS at 37C in a humidified atmosphere of
5.5% CO2, 5% O2 and balanced nitrogen until day 6 afterTable 1 Clinical summary of warming cycles of vitrified dono
Group A
No. of cycles 20
Mean age of donors 28.2±1.7
Mean age of recipients 42.4±6.0
Endometrium thickness (mm) 9.7±1.2
No. of eggs/warming cycle 7.6±1.5
Total No. of eggs warmed 151
No. of eggs survived (%) 142 (94.
No. of eggs fertilized (%) 114 (80.
No. of zygotes cleaved (%) 98 (86.0
No. of blastocysts (%) 26 (26.5
No. of clinical pregnancy (%) 9 (45.0)
No. of ongoing pregnancy or delivery (%) 8 (40.0)
Total No. of embryos transferred 39
Mean No. of embryos transferred 1.95±0.5
No. of embryos implanted (%) 12 (30.8
* Eggs from different donors were used in Groups A and B.inseminations. On Day 5, embryo development was eval-
uated and the best 1–2 embryos depending on embryo
quality were transferred.
All patients for embryo transfer received estradiol or-
ally and transvaginally. Intramuscular administration of
progesterone oil was initiated after about 14 days of es-
tradiol treatment. Endometrium thickness was measured
on the day of progesterone administration. Embryo
transfer occurred on the sixth or seventh day of proges-
terone administration and progesterone was continued
until the first serum β-hCG test two weeks after transfer.
Pregnancy diagnosis
Fourteen days after embryo transfer, a serum β-hCG was
checked. When the β-hCG showed > 5 mIU/ml, the
patients were regarded as a biochemical pregnancy. Four
weeks after embryo transfer, when a gestational sac with
fetal heartbeat was seen in the uterus under ultrasonog-
raphy, patients were diagnosed as having a clinical
pregnancy.
Statistical analysis
Interval and ratio data were analyzed with one-way
ANOVA and differences in categorical data between
groups were analyzed by Chi-square. A p value of less
than 0.05 was considered to be statistically different.
Results
Long time exposure of eggs in VS is better than short
time exposure
As shown in Table 1, in the present study, twenty cycles
used 151 eggs (7.6±1.5 per cycle) vitrified with the shortr eggs*







0) 174 (95.1) >0.05
3) 145 (83.3) >0.05
) 132 (91.0) >0.05





) 20 (45.5) >0.05
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vitrified with the long protocol. There were no differ-
ences between the two groups in terms of average age of
donors and recipients, egg survival rates after warming,
normal fertilization rates, percentages of cleaved
embryos and endometrium thickness in the recipients.
However, blastocyst development rate was significantly
lower (P< 0.001) in the short protocol group (26.5%)
than that in the long protocol group (50.8%). There were
no statistical differences in the clinical pregnancy, on-
going pregnancy and embryo implantation rates al-
though higher rates were found in the cycles using eggs
vitrified with the long protocol than those with the short
protocol.
More patients had blastocyst transfer and
cryopreservation if the eggs were frozen with the long
protocol
When we further analyzed the detailed embryo develop-
ment, as shown in Table 2, we found that if the short
protocol was used, 60% of the recipients had at least one
available blastocyst for transfer, and the pregnancy
(58.3%) and implantation (41.6%) rates with blastocyst
transfer were higher than those (25.0% pregnancy rate
and 13.3% implantation rate) without blastocyst transfer
that accounted for 40% of the cycles. Only 25% cycles
had spare blastocysts for cryopreservation. However,
when the long protocol was used, 87% of the recipients
had available blastocysts for transfer and 65.2% had
spare blastocysts for cryopreservation. The pregnancy
(70.0%) and implantation (50.0%) rates were also higher
in the patients with blastocyst transfer than those (33.3%
pregnancy rate and 16.7% implantation rate) in the
patients without a blastocyst transfer (Table 2).
Frozen eggs and fresh eggs had similar blastocyst
development and implantation rates
In the present study, 39 recipients received either fresh
eggs or frozen eggs (vitrified with the long protocol)
from 12 egg donors with an average of 3.2 recipients per
donor. When we further analyzed the data betweenTable 2 Summary of warming cycles of frozen donor eggs wi
Group A
Embryos for transfer with blastocyst(s) with
No. of transfers 12 8
% in the group 60 40
Mean age of recipients 44.9±5.1 38.5
Total No. of embryos transferred 24 15
Mean No. of embryos transferred 2.0±0.0 1.9±
No. of clinical pregnancy (%) 7 (58.3) 2 (2
No. of embryos implanted (%) 10 (41.6) 2 (1
*Data from same patients showed in Table 1 was analyzed.frozen eggs and fresh eggs, we did not find any differ-
ence in recipient’s ages, fertilization rates, blastocyst
formation rates, clinical pregnancy rates, ongoing
pregnancy rates and implantation rates between two
groups except that a higher (P <0.05) cleavage rate
(99.5%) was observed in the fresh eggs than that (92.6%)
in the frozen eggs (Table 3).
Because the blastocyst development is one of the most
important indicators for subsequent embryo implant-
ation, we further analyzed the 12 donors to evaluate if
there is any difference between fresh and frozen eggs in
the same individual donors. As shown in Figure 2, we
found that blastocyst development rates between fresh
and frozen eggs did not show statistical differences in all
12 donors.High implantation rate of the embryos resulting from
frozen patients own eggs
The long protocol was used to freeze eggs from patients
in the present study due to the lack of sperm or failed
semen collection at the egg retrieval day. The outcome
was summarized in Table 4. We obtained a 48.4% blasto-
cyst rate in the present study and all patients had blasto-
cysts for transfer. As a result, 5/6 patients had clinical
pregnancy and 4 patients had ongoing pregnancy with a
46.2% implantation rate.Discussion
In the present study, we demonstrated that by optimizing
a vitrification protocol, cryopreserved and fresh human
eggs have similar developmental competence with respect
to blastocyst formation. Transfer of embryos resulting
from frozen eggs produced similar clinical pregnancy and
implantation rates as fresh eggs. Our results indicate that
post warming survival, fertilization and cleavage are not
good indicators for frozen egg survival, but blastocyst de-
velopment is a better indicator for egg survival after freez-
ing/thawing. These results suggest that frozen egg banks
can be established after considering the efficiency of pro-
duction of high quality embryos and ongoing pregnancy.th or without blastocyst transfer*
Group B






5.0) 14 (70.0) 1 (33.3)
3.3) 19 (50.0) 1 (16.7)
Table 3 Summary of cycles of frozen eggs vs fresh eggs from 12 same donors
Frozen eggs* Fresh eggs P Value
No. of cycles 19 20 NA
Mean age of recipients 40.1±4.4 42.1±5.5 >0.05
No. of eggs/warming cycle 7.7±0.7 13.2±7.5 >0.05
Total No. of eggs warmed or used 147 263 NA
No. of eggs survived (%) 140 (95.2) NA NA
No. of eggs fertilized (%) 121 (86.4) 212 (80.6) >0.05
No. of zygotes cleaved (%) 112 (92.6) 211 (99.5) <0.05
No. of blastocysts (%) 56 (50.0) 125 (59.2) >0.05
No. of clinical pregnancy (%) 12 (63.2) 12 (60.0) >0.05
No. of ongoing pregnancy or delivery (%) 10 (52.6) 11 (55.0) >0.05
Total No. of embryos transferred 36 38 NA
Mean No. of embryos transferred 1.9±0.3 1.9±0.6 >0.05
No. of embryos implanted (%) 15 (41.7) 17 (44.7) >0.05
*All eggs were vitrified with the long protocol.
Figure 2 Direct comparison of fresh eggs and frozen eggs from
12 individual donors. There are no statistical significant differences
in the blastocyst development among 12 donors between fresh and
frozen eggs, in which 7 donors (marked by stars) had more or equal
blastocyst development rates as compared with their fresh eggs (A).
Up to 5 recipients received eggs from the same donor and the
numbers of cycles with frozen and fresh eggs are shown in B, and
the numbers of pregnant recipients from each donor are shown in
C. Long protocol was used to freeze the eggs and data was from
the same patients as shown in Table 3.
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important for egg vitrification. A few years ago,
Kuwayama developed a gradual exposure method for
egg vitrification using a specifically designed culture dish
and reported a high post warming survival rate [27].
However, a special culture dish is required for vitrifica-
tion of eggs with Kuwayama’s method, and also a par-
ticular handling is necessary during vitrification, which
makes it difficult to be followed by others. In some other
reports, oocytes were vitrified after being equilibrated in
different concentrations of ES made in-house [22,35].
However, such multiple step solutions are not commer-
cially available. In the protocol designed in the present
study, eggs were first placed in a drop of BS and then
merged to an adjacent drop of ES twice, finally placed in
a new drop of ES. Through this method, the eggs can
also be equilibrated from low concentration of CPAs to
high concentration CPAs with the standard commercial
embryo cryopreservation solutions.
Exposure time of eggs in different ES and VS before
vitrification varies among protocols. These steps appear
to be key components for successful cryopreservation of
eggs. Some researchers have used a maximum of 15 min-
utes in the ES depending on egg shape recovery
[20,34,38]. It may be difficult for embryologists to evalu-
ate the optimal equilibration status of an egg. To sim-
plify the protocol, a fixed time in each step may be
necessary for all laboratory technicians to follow. There-
fore, in the present study, we used a fixed time for a
total of 9 minutes in the ES and found that it was appro-
priate for vitrification of human eggs if the time in VS
was appropriate. This time period is obviously shorter
than other reports, which may be better for the egg’s via-
bility by reducing time of exposure eggs to the toxic
CPAs. We found that this method is very practical and
Table 4 Summary of egg vitrification and warming in the non-donor patients *














1 39 6/7 6 4 Blast x2 No No 0
2 30 4/4 3 3 Blast x2 Yes Yes 1
3 39 9/10 6 5 Blast x2 (2)** Yes Yes 1
4 34 10/10 8 8 Blast x2 Yes No 1
5 36 4/4 4 4 Blast x2 Yes Yes 1
6 29 8/8 7 7 Blast x2 (1)** Yes Yes 2
Total 41/43 34 31 13 (15)*** 5 4 6
% 95.3 82.9 91.2 48.4 83.3 66.7 46.2
*Eggs were vitrified with the long protocol.
**Numbers in the parentheses are the spare blastocysts for cryopreservation.
***Number in the parentheses is the total number of blastocysts (transferred and cryopreserved).
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method yielded high egg survival rates and favorable
clinical outcomes.
Another major key for egg vitrification is the exposure
time of eggs in the VS. It was reported that the short
time was essential for vitrification of human eggs and
embryos, because high concentrations of CPAs were
added in the VS [39]. Many early reports suggested that
the time should be less than 10 seconds [40]. However,
based on the studies in the mouse and human, short ex-
posure of eggs to VS was unfavorable to egg survival
and their competence to develop to blastocysts after vit-
rification [23,29,41]. In some early reports, it was found
that vitrified mouse and human oocytes could survive
and form embryos by using brief exposure to VS, but
the survival rates and blastocyst formation rates were
quite low [41-43]. In the present study, we used two dif-
ferent exposure times for vitrification, one was 45 sec-
onds and another was 90 seconds. We found that post
warming survival, fertilization and cleavage rates were
not statistically different between both groups. However
blastocyst development rates were significantly lower in
the short protocol group. This suggests that intracellular
water may not be completely replaced by CPAs in the
eggs exposed to VS for a shorter time. This could result
in damage to some organelles inside the eggs, which es-
cape detection via microscopic evaluation of general oo-
cyte morphology in the present study.
Outcomes from vitrified donor eggs and sibling fresh
donor eggs derived from the same stimulation cycles
were compared in the present study. There were no sig-
nificant differences in fertilization rates and blastocyst
development rates except that the cleavage rate was
lower in the frozen eggs than that in fresh eggs. Our
results are in contradistinction to a previous study that
indicated that embryo quality was affected during the
procedure of cryopreservation when frozen-thawed
oocytes were compared with fresh oocytes [24] butcomparable to those reported by others [20,25,44]. Our
results indicate that not only fertilization and blastocyst
development rates, but also the implantation rates were
similar between frozen and fresh eggs.
Creation of cryo-stored oocyte banks for oocyte dona-
tion has been advocated in recent years. Accumulated
data from different clinics indicate that oocyte cryo-
banking using vitrification represents advancement in
oocyte donation [20,25,44]. Egg banks have the potential
to lower cost and also overcome the obstacle of
synchronization of the recipients’ cycles with that of the
donor [20,21,23,26,45,46]. The sharing of cryo-donated
oocytes to several infertile recipients is a means of redu-
cing waiting time and cost for recipients. Most import-
antly, the use of frozen donated eggs can produce
satisfactory pregnancy rates [14,20,25,47]. In the present
study, we also obtained similar rates of blastocyst devel-
opment, embryo implantation and clinical pregnancy by
using frozen and fresh oocytes obtained from the same
donors. These results indicate that our optimized proto-
col for egg cryopreservation does not disturb eggs’ struc-
ture and function during freezing and thawing.
Most studies on egg cryopreservation were focused on
donated eggs from young women [20,21,23,25,26,46]. It
would be possible that eggs from young women or egg
donors can tolerate cryo-injuring better than eggs from
women with advanced maternal age or infertile women.
In the present study, with limited data, we observed high
survival, fertilization, and embryo implantation rates
when the eggs from infertility patients were vitrified/
warmed. These preliminary results are encouraging and
suggest that the protocol used in the present study is
not only appropriate for eggs from young donors, but
also for eggs from infertile patients.
Although the survival rate of egg vitrification can ex-
ceed 90% after warming, some eggs may not be able to
develop further after insemination. The survival rate im-
mediately after egg warming may not be a good
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example, in the present study, we found that the egg sur-
vival rate was high but blastocyst development rate was
low if the short protocol was used. These results indicate
that blastocyst development would be a better indicator
for egg cryopreservation and should be used as the pri-
mary indicator of egg survival or egg competence after
cryopreservation.
Conclusions
Our results indicate that human eggs can be successfully
vitrified with an easy to use protocol, and frozen human
eggs have a similar developmental competence to fresh
eggs with respect to the rates of blastocyst formation
and embryo implantation. Our results also indicate that
blastocyst formation and embryo implantation are two
key indicators to assess the success of an egg vitrification
protocol.
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